Know Cancer

or
forgot password

Development of a Platform for Next-generation DNA Sequencing Based Personalized Treatment for Cancer Patients: Protocol to Obtain Biopsies From Patients With Locally Advanced (Incurable) or Metastatic Cancer (CPCT - 02 Biopsy Protocol)


N/A
18 Years
N/A
Open (Enrolling)
Both
Solid Tumors, Metastatic Disease

Thank you

Trial Information

Development of a Platform for Next-generation DNA Sequencing Based Personalized Treatment for Cancer Patients: Protocol to Obtain Biopsies From Patients With Locally Advanced (Incurable) or Metastatic Cancer (CPCT - 02 Biopsy Protocol)


Inclusion Criteria:



- Locally advanced (incurable) or metastatic cancer from a histological or cytological
proven solid tumor

- Indication for systemic treatment with anti-cancer agents (with no treatment options
with curative intent)

- Measurable locally advanced (incurable) or metastatic lesion(s), according to RECIST
1.1 criteria.

- Safe biopsy of a metastatic or locally advanced lesion possible

- No contraindications for lidocaine (or its derivatives) and/or midazolam and/or
phentanyl

- Adequate organ function

- WHO performance status 0-2

- Age > 18 yr

- Expected adequacy to follow up

- Written informed consent

Exclusion Criteria:

- If one or more of the above mentioned inclusion criteria is not met

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor)

Outcome Measure:

• Percentage of patients enrolled in clinical intervention trials based on the mutational profile of their cancer genome

Outcome Time Frame:

3 months after baseline biopsy

Safety Issue:

No

Principal Investigator

Martijn P. Lolkema, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UMC Utrecht

Authority:

The Netherlands: Institutional Review Board of the Universerity Medical Center Utrecht, Dutch Cancer Institute in Amsterdam and Erasmus Medical Center in Rotterdam

Study ID:

NL35781.041.11

NCT ID:

NCT01855477

Start Date:

August 2011

Completion Date:

Related Keywords:

  • Solid Tumors
  • Metastatic Disease
  • Neoplasm Metastasis

Name

Location